Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III Trials
- DOI
- 10.1016/j.clon.2026.104032
- Published
- 2026-03
- Container
- Clinical Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clon.2026.104032,
title = {Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III Trials},
author = {M.S. Beshr and R.H. Shembesh and M.V. Nounou and M.E. Ali and E.C. Smyth and M. Abdelrahim and F. Pietrantonio and M. Elhadi and M. Moehler},
year = {2026},
journal = {Clinical Oncology},
doi = {10.1016/j.clon.2026.104032},
url = {https://doi.org/10.1016/j.clon.2026.104032}
}RIS
TY - JOUR TI - Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III Trials AU - M.S. Beshr AU - R.H. Shembesh AU - M.V. Nounou AU - M.E. Ali AU - E.C. Smyth AU - M. Abdelrahim AU - F. Pietrantonio AU - M. Elhadi AU - M. Moehler PY - 2026 JO - Clinical Oncology DO - 10.1016/j.clon.2026.104032 UR - https://doi.org/10.1016/j.clon.2026.104032 ER -
APA
Beshr, M., Shembesh, R., Nounou, M., Ali, M., Smyth, E., Abdelrahim, M., Pietrantonio, F., Elhadi, M., & Moehler, M. (2026). Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III Trials. Clinical Oncology. https://doi.org/10.1016/j.clon.2026.104032
Source records
- crossref · retrieved 2026-09-25T19:59:05.046Z